Physician profile
James A Mccarthy
NPI 1245337963
$1,695.60
in general payments reported to CMS, 2019-2025
19 companies · $73.30 in 2025
The $73.30 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $107 · 2021: $191 · 2022: $604 · 2023: $203 · 2024: $237 · 2025: $73.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $512.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $602.30 | 2021-2025 | |
| Genzyme Corporation | $140.04 | 2021-2023 | |
| Allergan, INC. | $115.55 | 2019-2022 | |
| Sunovion Pharmaceuticals INC. | $113.62 | 2019-2022 | |
| Amneal Pharmaceuticals LLC | $112.52 | 2022-2024 | Rytary, Ongentys |
| Lilly USA, LLC | $103.10 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $100.13 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $72.02 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $51.98 | 2019-2022 | |
| Mdd US Operations, LLC | $48.58 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $40.65 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $34.42 | 2019 | |
| Biogen, INC. | $32.43 | 2019-2022 | |
| Celgene Corporation | $28.39 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $25.83 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Adamas Pharmaceuticals, INC. | $20.81 | 2019 | |
| Pfizer INC. | $19.94 | 2025 | |
| Siemens Medical Solutions USA, INC. | $19.65 | 2024 | Atellica Ch 930 Analyzer |
| Grifols USA, LLC | $13.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mccarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.